Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies
Clinical trial NCT06948097 · RECRUITING
Trial details
- NCT number
- NCT06948097
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-26
- Primary completion
- 2028-07-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.